tradingkey.logo

Sanofi SA

SNY
View Detailed Chart

45.170USD

-4.080-8.28%
Market hours ETQuotes delayed by 15 min
113.25BMarket Cap
16.68P/E TTM

Sanofi SA

45.170

-4.080-8.28%
Intraday
1m
30m
1h
D
W
M
D

Today

-8.28%

5 Days

-9.95%

1 Month

-6.50%

6 Months

-16.58%

Year to Date

-6.34%

1 Year

-12.61%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 10 analysts
BUY
Current Rating
64.049
Target Price
30.05%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

172
Total
5
Median
8
Average
Company name
Ratings
Analysts
Sanofi SA
SNY
10
Biogen Inc
BIIB
37
Vertex Pharmaceuticals Inc
VRTX
34
Amgen Inc
AMGN
33
Alnylam Pharmaceuticals Inc
ALNY
33
Gilead Sciences Inc
GILD
30
1
2
3
...
35

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(8)
Neutral(4)
Buy(0)
Indicators
Sell(2)
Neutral(4)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
0.316
Neutral
RSI(14)
50.651
Neutral
STOCH(KDJ)(9,3,3)
58.517
Sell
ATR(14)
0.764
Low Volatility
CCI(14)
13.037
Neutral
Williams %R
47.238
Neutral
TRIX(12,20)
0.043
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
49.716
Sell
MA10
49.239
Sell
MA20
48.923
Sell
MA50
49.523
Sell
MA100
51.693
Sell
MA200
51.539
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
Ticker SymbolSNY
CompanySanofi SA
CEOMr. Paul Hudson, Ph.D.
Websitehttps://www.sanofi.com/
KeyAI